JAK2 and acute lymphoblastic leukemia: In this study, we modeled acquired resistance to rux using in vitro models of high-risk JAK2 fusion genes in ALL to investigate potential resistance mechanisms and cross-resistance, in anticipation of such observations in the clinic.